StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of Vascular Biogenics stock remained flat at $0.25 on Wednesday. The company’s stock had a trading volume of 318,244 shares, […]
StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of NASDAQ:VBLT remained flat at $0.25 during midday trading on Wednesday. The company had a trading volume […]
StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note released on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Down 7.5 % NASDAQ VBLT opened at $0.26 on Tuesday. The company has a market capitalization of $17.91 million, a price-to-earnings […]
StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of NASDAQ VBLT opened at $0.26 on Tuesday. The stock has a market capitalization of $17.91 million, a […]
Investment analysts at StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Free Report) in a report released on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Vascular Biogenics Trading Down 6.6 % NASDAQ VBLT opened at $0.28 on Tuesday. The stock has a market cap of $19.53 million, […]